Doubling down with CAR-T cell cancer immunotherapy: a two-step recognition circuit enables discrimination between target antigen high and low cancer cells
Crossref DOI link: https://doi.org/10.1038/s41392-021-00706-0
Published Online: 2021-07-28
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Charo, Jehad
Gomes, Bruno
Text and Data Mining valid from 2021-07-28
Version of Record valid from 2021-07-28
Article History
Received: 28 April 2021
Revised: 16 June 2021
Accepted: 1 July 2021
First Online: 28 July 2021
Competing interests
: Authors are employees and stockholders at ROCHE.